IBDEI1IX ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27054,1,3,0)
 ;;=3^Monoplegia of LL, Dom Side
 ;;^UTILITY(U,$J,358.3,27054,1,4,0)
 ;;=4^438.41
 ;;^UTILITY(U,$J,358.3,27054,2)
 ;;=^317917
 ;;^UTILITY(U,$J,358.3,27055,0)
 ;;=438.42^^160^1755^16
 ;;^UTILITY(U,$J,358.3,27055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27055,1,3,0)
 ;;=3^Monoplegia of LL, NonDom Side
 ;;^UTILITY(U,$J,358.3,27055,1,4,0)
 ;;=4^438.42
 ;;^UTILITY(U,$J,358.3,27055,2)
 ;;=^317918
 ;;^UTILITY(U,$J,358.3,27056,0)
 ;;=342.90^^160^1755^6
 ;;^UTILITY(U,$J,358.3,27056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27056,1,3,0)
 ;;=3^Hemiplegia,Unspec Side
 ;;^UTILITY(U,$J,358.3,27056,1,4,0)
 ;;=4^342.90
 ;;^UTILITY(U,$J,358.3,27056,2)
 ;;=^303267
 ;;^UTILITY(U,$J,358.3,27057,0)
 ;;=342.91^^160^1755^4
 ;;^UTILITY(U,$J,358.3,27057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27057,1,3,0)
 ;;=3^Hemiplegia,Affecting Dominant Side
 ;;^UTILITY(U,$J,358.3,27057,1,4,0)
 ;;=4^342.91
 ;;^UTILITY(U,$J,358.3,27057,2)
 ;;=^303268
 ;;^UTILITY(U,$J,358.3,27058,0)
 ;;=342.92^^160^1755^5
 ;;^UTILITY(U,$J,358.3,27058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27058,1,3,0)
 ;;=3^Hemiplegia,Affecting Nondominant Side
 ;;^UTILITY(U,$J,358.3,27058,1,4,0)
 ;;=4^342.92
 ;;^UTILITY(U,$J,358.3,27058,2)
 ;;=^303269
 ;;^UTILITY(U,$J,358.3,27059,0)
 ;;=345.90^^160^1755^3
 ;;^UTILITY(U,$J,358.3,27059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27059,1,3,0)
 ;;=3^Epliep NOS w/o Intr Epil
 ;;^UTILITY(U,$J,358.3,27059,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,27059,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,27060,0)
 ;;=427.31^^160^1756^3
 ;;^UTILITY(U,$J,358.3,27060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27060,1,3,0)
 ;;=3^Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,27060,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,27060,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,27061,0)
 ;;=V45.81^^160^1756^2
 ;;^UTILITY(U,$J,358.3,27061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27061,1,3,0)
 ;;=3^Aortocoronary Bypass
 ;;^UTILITY(U,$J,358.3,27061,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,27061,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,27062,0)
 ;;=414.00^^160^1756^9
 ;;^UTILITY(U,$J,358.3,27062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27062,1,3,0)
 ;;=3^Cor Atheroscl Unsp Typ-Ves
 ;;^UTILITY(U,$J,358.3,27062,1,4,0)
 ;;=4^414.00
 ;;^UTILITY(U,$J,358.3,27062,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,27063,0)
 ;;=414.01^^160^1756^8
 ;;^UTILITY(U,$J,358.3,27063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27063,1,3,0)
 ;;=3^Cor Atheroscl Natv C Vsl
 ;;^UTILITY(U,$J,358.3,27063,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,27063,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,27064,0)
 ;;=425.4^^160^1756^17
 ;;^UTILITY(U,$J,358.3,27064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27064,1,3,0)
 ;;=3^Prim Cardiomyopathy Nec
 ;;^UTILITY(U,$J,358.3,27064,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,27064,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,27065,0)
 ;;=428.0^^160^1756^7
 ;;^UTILITY(U,$J,358.3,27065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27065,1,3,0)
 ;;=3^Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,27065,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,27065,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,27066,0)
 ;;=496.^^160^1756^5
 ;;^UTILITY(U,$J,358.3,27066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27066,1,3,0)
 ;;=3^Chr Airway Obstruct Nec
 ;;^UTILITY(U,$J,358.3,27066,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,27066,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,27067,0)
 ;;=491.21^^160^1756^13
 ;;^UTILITY(U,$J,358.3,27067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27067,1,3,0)
 ;;=3^Ob Ch Bronchitis W Exacerb
 ;;^UTILITY(U,$J,358.3,27067,1,4,0)
 ;;=4^491.21
 ;;
 ;;$END ROU IBDEI1IX
